Described are pharmaceutical compositions comprising combinations of at least one anti-epileptic compound that demonstrate pain alleviating properties, such as gabapentin or pregabalin, and at least one NSAID, such as naproxen or celecoxib. It has been discovered that the administration of anti-epileptic compounds that demonstrate pain-alleviating properties in these combinations can result in an improved reduction in the frequency and severity of pain. It is also believed that the incidence of unwanted side effects can be reduced by these combinations in comparison to using higher doses of a single agent treatment to achieve a similar therapeutic effect.
Combination of an analgesic with anti-epileptic properties and a NSAID